GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » All Cosmos Bio-Tech Holding Corp (TPE:4148) » Definitions » Change In Receivables

All Cosmos Bio-Tech Holding (TPE:4148) Change In Receivables : NT$241 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is All Cosmos Bio-Tech Holding Change In Receivables?

All Cosmos Bio-Tech Holding's change in receivables for the quarter that ended in Mar. 2024 was NT$-45 Mil. It means All Cosmos Bio-Tech Holding's Accounts Receivable increased by NT$45 Mil from Dec. 2023 to Mar. 2024 .

All Cosmos Bio-Tech Holding's change in receivables for the fiscal year that ended in Dec. 2023 was NT$249 Mil. It means All Cosmos Bio-Tech Holding's Accounts Receivable declined by NT$249 Mil from Dec. 2022 to Dec. 2023 .

All Cosmos Bio-Tech Holding's Accounts Receivable for the quarter that ended in Mar. 2024 was NT$491 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. All Cosmos Bio-Tech Holding's Days Sales Outstanding for the three months ended in Mar. 2024 was 85.57.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. All Cosmos Bio-Tech Holding's liquidation value for the three months ended in Mar. 2024 was NT$1,422 Mil.


All Cosmos Bio-Tech Holding Change In Receivables Historical Data

The historical data trend for All Cosmos Bio-Tech Holding's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

All Cosmos Bio-Tech Holding Change In Receivables Chart

All Cosmos Bio-Tech Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 439.84 -211.19 138.51 -233.48 249.25

All Cosmos Bio-Tech Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.23 -65.24 256.00 94.71 -44.59

All Cosmos Bio-Tech Holding Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$241 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


All Cosmos Bio-Tech Holding  (TPE:4148) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

All Cosmos Bio-Tech Holding's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=490.942/523.545*91
=85.57

2. In Ben Graham's calculation of liquidation value, All Cosmos Bio-Tech Holding's accounts receivable are only considered to be worth 75% of book value:

All Cosmos Bio-Tech Holding's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1685.693-879.465+0.75 * 490.942+0.5 * 495.87
=1,422

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


All Cosmos Bio-Tech Holding Change In Receivables Related Terms

Thank you for viewing the detailed overview of All Cosmos Bio-Tech Holding's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


All Cosmos Bio-Tech Holding (TPE:4148) Business Description

Traded in Other Exchanges
N/A
Address
PLO 650, Jalan Keluli 7, Pasir Gudang Industrial Estate, Johor Bahru, JHR, MYS, 81700
All Cosmos Bio-Tech Holding Corp focuses on the production and marketing of biochemical and bio-organic fertilizers and agriculture-related activities. The company produces 30 different types of fertilizers for the vibrant Malaysian market as well as for the larger Asia Pacific Region. The products are also exported to Taiwan, Indonesia, Vietnam, China, Cambodia and Philippines. Its segments are All Cosmos Industries Sdn. Bhd. (ACI), Sabah Softwoods Hybrid Fertiliser Sdn. Bhd. (SSHF) and others. It generates revenue from Malaysia.

All Cosmos Bio-Tech Holding (TPE:4148) Headlines

No Headlines